mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.38 |
0.2 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.34 |
0.2 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
3e-10 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
4e-09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
6e-09 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
5e-09 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
1e-08 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-08 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.2 |
0.5 |